Login
Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
The DEPT OF DEFENSE | DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA) has issued a Tender notice for the procurement of a Resuscitation and Prevention of Ischemiainduced Dysfunction Rapiid Ta1ta2 in the USA. This Tender notice was published on 28 May 2026 and is scheduled to close on 24 Jun 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 142177153, while the tender notice number is DARPA-PS-26-124 and Registering on the platform.
Procurement Summary
Country: USA
Summary: Resuscitation and Prevention of Ischemiainduced Dysfunction Rapiid Ta1ta2
Deadline: 24 Jun 2026
Posting Date: 28 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 142177153
Document Ref. No.: DARPA-PS-26-124
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details Tender Details The Resuscitation and Prevention of Ischemia-induced Dysfunction (RAPIID) program seeks to deliver a transformative, end-to-end resuscitation system that redefines far-forward trauma care. RAPIID aims for this system to be fieldable, usable, and scalable, providing a capability equivalent or superior to stored whole blood in early resuscitation while removing dependence on cold chain and donor logistics. RAPIID seeks to do this by developing a blood analog system (BAS) comprising sequentially administered blood analog components, integrated with ruggedized delivery formats, point-of-care diagnostics, and clinical practice guidelines (CPGs). To maximize post-program viability of developed products, RAPIID will develop and execute effective regulatory and commercialization strategies and accelerate advanced development through technology readiness level (TRL) 7 (Scale-up and Phase II Clinical Trials)1 for blood analog components and TRL 8 (Clinical Studies)2 for devices and diagnostics. This solicitation is to request proposals addressing ONLY Phase 1 of Task Area (TA)-1 and/or TA-2. Documents
Notice ID: darpa-ps-26-124
Department/Ind. Agency: dept of defense
Sub-tier: defense advanced research projects agency (darpa)
Office: def advanced research projects agcy
Product Service Code: ac12 - national defense r&d services; department of defense - military; applied research
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Inactive Dates: jul 24, 2026
Inactive Policy: manual
Procurement Documents for USA
Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA
Want To Bid in This Tender?
Get Local Agent Support in USA and 60 More Countries.
View Tenders By
Sign in with Google